Metropolis Healthcare Ltd.

Incorporated in 1980, Mumbai based Metropolis Healthcare Limited is a chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.The company also provides analytical and support services for the clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.Metropolis offers 3,480 clinical laboratory tests and 524 profiles which combines a variety of tests for the specific disease. To provide better services, it has implemented a 'hub and spoke' model. Outside India, the company has a presence in Ghana, Zambia, Kenya, Sri Lanka and Mauritius for laboratory operations and in UAE, Nepal, Nigeria, and Oman for 3rd party services.It has been recognized by Biotrains for "excellence in customer service and delivery" and FICCI for "service excellence (diagnostic center)" and LH Insights for "best in health and fitness" in 2018.The competitive strengths of the company are:1. Well positioned for expected industry growth2. Widespread operational network3. Comprehensive test menu4. Focus on quality and customer service5. Robust information technology structure

Metropolis Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects: